New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis | Synapse
March 3, 2026Open Access
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis
Puntos clave
Access to CAR T-cell therapies for children's cancer requires breaking down existing barriers, enhancing availability.
Key findings from the multistakeholder analysis show critical challenges that hinder effective development and delivery of therapies.
Approach includes a thorough multistakeholder analysis to identify key factors affecting access and development of CAR T-cell therapies.
Implications highlight the need for collaborative efforts across sectors to improve access for vulnerable populations.